Publications:

Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma.

Genome Medicine

Nam, Yoonhee Y; Koo, Harim H; Yang, Yingxi Y; Shin, Sang S; Zhu, Zhihan Z; Kim, Donggeon D; Cho, Hee Jin HJ; Mu, Quanhua Q; Choi, Seung Won SW; Sa, Jason K JK; Seo, Yun Jee YJ; Kim, Yejin Y; Lee, Kyoungmin K; Oh, Jeong-Woo JW; Kwon, Yong-Jun YJ; Park, Woong-Yang WY; Kong, Doo-Sik DS; Seol, Ho Jun HJ; Lee, Jung-Il JI; Park, Chul-Kee CK; Lee, Hye Won HW; Yoon, Yeup Y; Wang, Jiguang J

Publication Date: 2023-03-13

Variant appearance in text: EGFR: C636W

PubMed Link: 36915208

Variant Present in the following documents:

• 13073_2023_1165_MOESM1_ESM.xlsx, sheet 2

View BVdb publication page

Therapeutic Efficacy of GC1118, a Novel Anti-EGFR Antibody, against Glioblastoma with High EGFR Amplification in Patient-Derived Xenografts.

Cancers

Lee, Kyoungmin K; Koo, Harim H; Kim, Yejin Y; Kim, Donggeon D; Son, Eunju E; Yang, Heekyoung H; Lim, Yangmi Y; Hur, Minkyu M; Lee, Hye Won HW; Choi, Seung Won SW; Nam, Do-Hyun DH

Publication Date: 2020-10-31

Variant appearance in text: EGFR: C636W

PubMed Link: 33142709

Variant Present in the following documents:

• Main text
• cancers-12-03210.pdf

View BVdb publication page